Encompass Health Corp: director Reidy Christopher R received 304 shares

What happened

• Reidy Christopher R, a director, received a total of 304 shares: 20 shares credited as restricted stock units (RSUs) on Oct 15, 2026 at $0.00 and 284 shares acquired on Oct 19, 2026 at $126.89 per share for $36,037.

Key details

• Transaction dates and prices: Oct 15, 2026 — 20 RSUs @ $0.00 (award); Oct 19, 2026 — 284 shares @ $126.89 (acquisition) for a reported $36,037.
• Transaction code: A (award/acquisition) for both entries.
• Shares owned after the transaction: Not reported on this Form 4.
• Relevant footnotes from the filing:
  • F1: The 20 RSUs were credited under outstanding RSU award agreements in connection with the $0.21 per share dividend paid Oct 15, 2026; the closing price on the dividend payment date was $127.77.
  • F2: The 284 shares were purchased by the Directors Deferred Stock Investment Plan with the director's quarterly fee deferral and the Oct 15 dividend of $0.21 per share; purchases are made in the market by the plan administrator for participants' accounts.
  • F3: The $126.89 per share price is a weighted average; the filing states purchases occurred at prices ranging from $126.83 to $126.89 and that the reporting person will provide details on request.
• Filing date and timeliness: Form filed Oct 19, 2026; the filing does not indicate it was late.

Why it may matter

• The Oct 15 entry is an RSU award tied to a dividend payment and is not a direct open-market purchase by the director.
• The Oct 19 entry reflects shares acquired through the directors' deferred stock plan, with purchases made in the market by the plan administrator using deferred fees and dividends.
• A filing does not show why the insider traded or why the company acted.